Renin inhibition in patients with chronic kidney disease: Is it conclusively non-indicated?

Abstract

Get full access to this article

View all access options for this article.

References

Parving

Brenner

Mcmurray

. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012; 367: 2204–2213

Parving

Persson

Lewis

. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008; 358: 2433–2446.

Sarafidis

Bakris

. Does evidence support renin–angiotensin system blockade for slowing nephropathy progression in elderly persons? Ann Intern Med 2009;150: 731–733.

Pimenta

Oparil

. Renin inhibitors: Novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering? Cardiol Clin 2008; 26: 527–535.

Sarafidis

Ruilope

. Cardiorenal disease development under chronic renin–angiotensin–aldosterone system suppression. J Renin Angiotensin Aldosterone Syst 2012; 13: 217–219.

Bakris

Oparil

Purkayastha

. Randomized study of antihypertensive efficacy and safety of combination aliskiren valsartan vs. valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus. J Clin Hypertens (Greenwich) 2013; 15: 92–100.